519 related articles for article (PubMed ID: 28160779)
21. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
22. Regulator role of HPV E7 protein on miR-21 expression in cervical carcinoma cells and its functional implication.
Kong Q; Wang W; Li P
Int J Clin Exp Pathol; 2015; 8(12):15808-13. PubMed ID: 26884851
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells proliferation apoptosis, migration and invasion.
López JA; Alvarez-Salas LM
Biochem Biophys Res Commun; 2011 Jun; 409(3):513-9. PubMed ID: 21600876
[TBL] [Abstract][Full Text] [Related]
24. HPV16
Pulati N; Zhang Z; Gulimilamu A; Qi X; Yang J
J Gene Med; 2019 Nov; 21(11):e3126. PubMed ID: 31498525
[TBL] [Abstract][Full Text] [Related]
25. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas.
Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M
Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871
[No Abstract] [Full Text] [Related]
26. LncRNA HOTAIR promotes proliferation and inhibits apoptosis by sponging miR-214-3p in HPV16 positive cervical cancer cells.
Zhou Y; Wang Y; Lin M; Wu D; Zhao M
Cancer Cell Int; 2021 Jul; 21(1):400. PubMed ID: 34320988
[TBL] [Abstract][Full Text] [Related]
27. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells.
Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405
[TBL] [Abstract][Full Text] [Related]
28. MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1.
Huang P; Xi J; Liu S
Biomed Pharmacother; 2016 Oct; 83():850-856. PubMed ID: 27505862
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
Wei XM; Wang Q; Gao SJ; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
Au Yeung CL; Tsang TY; Yau PL; Kwok TT
Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
[TBL] [Abstract][Full Text] [Related]
31. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
34. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
[TBL] [Abstract][Full Text] [Related]
35. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y
Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895
[TBL] [Abstract][Full Text] [Related]
37. miR-9, miR-21, miR-27b, and miR-34a Expression in HPV16/58/52-Infected Cervical Cancer.
Liu M; Wang W; Chen H; Lu Y; Yuan D; Deng Y; Ran D
Biomed Res Int; 2020; 2020():2474235. PubMed ID: 33015156
[TBL] [Abstract][Full Text] [Related]
38. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
39. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
Liu X
Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]